Author: NCV Newswire

[ad_1] March 13, 2024 at 7:38 am Published by NCV Newswire   The Cannabist Company Reports Fourth Quarter and Full Year 2023 Results NEW YORK–(BUSINESS WIRE), 03/13/24–The Cannabist Company Holdings Inc. (NEO: CBST) (OTCQX: CBSTF) (FSE: 3LP) (“The Cannabist Company” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today reported its financial and operating results for the fourth quarter and full year ended December 31, 2023. All financial information presented in this release is in U.S. GAAP and in thousands of U.S. dollars, unless otherwise noted. Fourth Quarter…

[ad_1] March 13, 2024 at 8:01 am Published by NCV Newswire   Cresco Labs Reports Fourth Quarter & Full Year 2023 Financial Results Demonstrating Significant Profitability and Cash Flow Improvements Continued execution of Year-of-the-Core strategy delivers strong gains to the bottom line and 3x improvement in full-year Operating Cash Flow CHICAGO–(BUSINESS WIRE)–Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today released its financial and operating results for the fourth quarter and year ended…

[ad_1] March 13, 2024 at 7:24 am Published by NCV Newswire AYR Wellness Reports Fourth Quarter and Full Year 2023 Results FY 2023 Revenue up 10% to $463.6 Million, Excluding Discontinued Operations FY 2023 GAAP Loss from Operations Improved to $37.2 Million, Excluding Discontinued Operations FY 2023 Adjusted EBITDA1 up 51% to $114.0 Million, with Adjusted EBITDA Margin of 25% Completed Plan of Arrangement Transactions, Including Extending the Maturity of all of its Senior Notes and Certain Other Debt by Two Years, in February 2024 MIAMI, March 13, 2024 (GLOBE NEWSWIRE) — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR”…

[ad_1] AWH ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS Q4 2023 Net Revenue Increased 25% Year-over-Year to $140 million Q4 2023 Adjusted EBITDA Increased 15% Year-over-Year to $32 million Full Year 2023 Net Revenue Increased 28% Year-over-Year to $519 million Full Year 2023 Adjusted EBITDA Increased 14% Year-over-Year to $107 million First Full Year of Positive Cash from Operations and Positive Free Cash Flow Company Ended Q4 2023 with $73 Million of Cash and Cash Equivalents NEW YORK, March 12, 2024 /PRNewswire/ – Ascend Wellness Holdings, Inc. (“AWH” or the “Company”) (CSE: AAWH.U) (OTCQX: AAWH), a vertically integrated…

[ad_1] March 6, 2024 at 4:15 pm Published by NCV Newswire Curaleaf Reports Fourth Quarter and Full Year Ended 2023 Results Fourth quarter 2023 revenue of $345 million, representing an increase of 4% quarter-over-quarter. Fourth quarter 2023 adjusted EBITDA(1) of $83 million, representing 24% of revenue, a 490 basis point improvement year-over-year. Full Year 2023 cash flow from continuing operations of $91 million. NEW YORK, March 6, 2024 /PRNewswire/ — Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis, today reported its financial and operating results for the fourth…

[ad_1] Planet 13 Announces Pricing of Public Offering of Units LAS VEGAS, March 5, 2024 /PRNewswire/ – Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), today announced the pricing of its previously announced underwritten public offering (the “Offering”). Pursuant to the Offering, the Company will issue and sell 18,750,000 units of the Company (the “Units”) at an issue price of US$0.60 per Unit for total gross proceeds to the Company of approximately US$11.3 million. Each Unit will consist of one share (each, a “Share”) of common stock, no par value, of the Company (“Common Stock”)…

[ad_1] You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. Friends, Two weeks ago, we discussed how the MSOs have plunged. They ended February a bit lower than they were then, as we detailed in the article linked below that we published today. Even after the big pullback in February of 9.2%, the New Cannabis Ventures American Cannabis Operator Index was still up 27.2% year-to-date through the…

[ad_1] March 1, 2024 at 12:50 pm Published by NCV Newswire Secured Party Rep: David EngelPhone: 404-993-7077Email: engelcapitaladvisors@gmail.comWebsite: Fullmoonrealestateinvestments.com Auctioneer: Michael SapersteinPhone: 617-227-6553Email: msaperstein@pesco.com   Assets of Middlesex Integrative Medicine, Inc. & MIM Management, LLC to be sold at Public Auction All assets to be sold at an Article 9 Auction Sale, Friday, March 15, 2024 at 11:00 AM. MIM Massachusetts Convertible Notes Series III, a series of S Curve, LLC, in its capacity as the Secured Party (the “Secured Party”) of Middlesex Integrative Medicine, Inc. and MIM Management, LLC (together “MIM”) is conducting an article 9 auction sale of…

[ad_1] February 29, 2024 at 6:02 am Published by NCV Newswire Verano Announces Fourth Quarter and Full Year 2023 Financial Results Record Revenue of $938 Million Increased 2023 Net Cash Provided by Operating Activities by 16% to $110 Million Generated $73 million in Free Cash Flow1 for 2023, Meeting Guidance CHICAGO, Feb. 29, 2024 (GLOBE NEWSWIRE) — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced its financial results for the fourth quarter and full year ended December 31, 2023, which were prepared in accordance with U.S. Generally Accepted Accounting…

[ad_1] February 29, 2024 at 6:20 am Published by NCV Newswire Trulieve Reports Fourth Quarter and Full Year 2023 Results Highlighting Year End Momentum and Cash Generation Fourth quarter performance delivered highest revenue and gross margin for the year Record cash flow from operations of $202 million and free cash flow of $161 million* in 2023 Expect 2024 cash flow from operations of at least $225 million TALLAHASSEE, Fla., Feb. 29, 2024 /PRNewswire/ — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., today announced its results for the…

[ad_1]   CHICAGO and VANCOUVER, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today reported its financial results for the fourth quarter and full year ended December 31, 2023. Financial results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and all currency is in U.S. dollars. Highlights for the fourth quarter ended December 31, 2023: Fourth quarter revenue of $278 million increased 7% year-over-year. Cash at quarter end of $162 million.…

[ad_1] Organigram Reports First Quarter Fiscal 2024 Results Achieved positive cash flow from operations, solidified #2 market position in Canada among licensed producers, significantly improved margins sequentially quarter-over-quarter, and closed first $41.5 million tranche of previously announced $124.6 million investment from BAT HIGHLIGHTS $124.6 million strategic investment from BAT announced in November 2023 approved by shareholders, with first of three tranches now funded at $3.22 per share for proceeds of $41.5 million Achieved positive Adjusted EBITDA¹ and positive cash flow from operations of $7.7 million Improved sequential quarter-over-quarter adjusted gross margin² from 17% in Q4 Fiscal 2023 (references to “Fiscal…